Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposingMarcelo Falchetti, Alfeu Zanotto‐Filho, Helena Souza Zancanaro et al.|Computers in Biology and Medicine|2022Cited by 12